Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Reducing Asthma Disparities by Improving Provider-Patient Communication

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00181194
Recruitment Status : Completed
First Posted : September 16, 2005
Last Update Posted : August 21, 2018
Sponsor:
Collaborator:
National Institutes of Health (NIH)
Information provided by (Responsible Party):
Johns Hopkins University

Tracking Information
First Submitted Date September 13, 2005
First Posted Date September 16, 2005
Last Update Posted Date August 21, 2018
Study Start Date May 2005
Actual Primary Completion Date December 2006   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: September 13, 2005)
  • Accuracy of Provider Assessment of Asthma Severity
  • Accuracy of Clinician Assessment of Patient Adherence
  • Assessment of appropriateness of asthma treatment (consistency of care with asthma guidelines
  • Patient satisfaction with provider-patient communication and medical care
Original Primary Outcome Measures Same as current
Change History
Current Secondary Outcome Measures
 (submitted: September 13, 2005)
These outcomes include indicators of poor asthma control such as health care service use for asthma exacerbations (unscheduled office visits, ER visits, hospitalizations) and use of oral corticosteroid and overuse of inhaled beta-agonist medications.
Original Secondary Outcome Measures Same as current
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Reducing Asthma Disparities by Improving Provider-Patient Communication
Official Title Reducing Asthma Disparities by Improving Provider-Patient Communication About Asthma Severity and Adherence With Therapy
Brief Summary The purpose of this study will be to assess the impact of a culturally-sensitive, patient-focused asthma communication instrument (ACCI) designed to enhance provider-patient communication by prompting and guiding providers in assessments of disease severity and discussion of adherence behaviors with minority patients with asthma.
Detailed Description Improving communication between health care providers and their patients is the critical first step in efforts designed to reduce asthma-related health disparities in urban areas. Improving communication will help providers tailor asthma therapies to their patients' needs, and help providers and patients to overcome barriers (e.g., concerns about adverse effects) to adherence with those asthma treatment plans.
Study Type Observational
Study Design Not Provided
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Not Provided
Study Population Not Provided
Condition Asthma
Intervention Device: Asthma Control and Communication Instrument
Study Groups/Cohorts Not Provided
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Completed
Estimated Enrollment
 (submitted: September 13, 2005)
350
Original Enrollment Same as current
Actual Study Completion Date December 2012
Actual Primary Completion Date December 2006   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • are able to provide informed consent;
  • report physician-diagnosed asthma;
  • report asthma symptoms and/or use of short-acting reliever medication at least twice weekly in the past month.

Exclusion Criteria:

  • state they do not have asthma;
  • have mild intermittent disease
  • no recent evidence of disease activity.
Sex/Gender
Sexes Eligible for Study: All
Ages 12 Years to 85 Years   (Child, Adult, Older Adult)
Accepts Healthy Volunteers No
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries United States
Removed Location Countries  
 
Administrative Information
NCT Number NCT00181194
Other Study ID Numbers 20021855
Has Data Monitoring Committee Not Provided
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement Not Provided
Responsible Party Johns Hopkins University
Study Sponsor Johns Hopkins University
Collaborators National Institutes of Health (NIH)
Investigators
Principal Investigator: Gregory B Diette, MD, MHS Johns Hopkins University
PRS Account Johns Hopkins University
Verification Date August 2018